Abstract
FOXA2 expression combined with mutant KRAS drives invasive mucinous adenocarcinoma of the lung by synergistically promoting a mucous transcriptional program, suggesting strategies for targeting this lung cancer type that lacks effective therapies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have